How to help patients manage their dyslipidemia: A primary care physician–pharmacist team intervention
| Autor: | Jacques Genest, Eveline Hudon, Lyne Lalonde, Sylvie Perreault, Marie-Claude Vanier, Lucie Blais, Julie Villeneuve, Diane Lamarre, Marie-Thérèse Lussier |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
business.industry health care facilities manpower and services education Psychological intervention Primary care physician Pharmacist Pharmaceutical Science Pharmacy medicine.disease law.invention Pharmacotherapy Randomized controlled trial Ambulatory care law health services administration Family medicine Medicine Medical prescription business health care economics and organizations Dyslipidemia |
| Zdroj: | Canadian Pharmacists Journal. 140:300-305 |
| ISSN: | 1913-701X 1715-1635 |
| DOI: | 10.3821/1913-701x(2007)140[300:hthpmt]2.0.co;2 |
| Popis: | Dyslipidemia treatment in primary care is far from optimal — adherence and persistence to pharmacotherapy are low, and physicians tend not to titrate statin dosages. Consequently, a large proportion of patients do not attain their recommended lipid targets. This has serious clinical and economic consequences. Several studies have shown that community-pharmacist interventions and collaborative management of pharmacotherapy by physicians and pharmacists improve dyslipidemia treatment. In Quebec, as a result of legislative changes (Bill 90) made in 2002, community pharmacists may initiate and adjust drug therapy in accordance with a physician’s prescription and request laboratory analyses when needed. This new legislation increases the potential for a physician-pharmacist team approach to the management of dyslipidemic patients. In Quebec, in order to implement these collaborative practices, a treatment protocol has to be approved by members of a hospital’s Conseil des Medecins, Dentistes et Pharmaciens (Council of Doctors, Dentists, and Pharmacists). In this article, we present a treatment protocol for the management of statin therapy that was developed by pharmacists (LL, JV, DL, MCV, SP), family physicians (MTL, EH), and a cardiologist (JG) as part of a randomized controlled trial. The treatment protocol describes a physician-pharmacist team intervention for the management of patients with dyslipidemia in a primary care setting. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|